Nicolas Wickens completed his Doctorate from the Nelson Mandela University in South Africa. He is a lecturer of pathology in the Department of Medical Technology and Radiography in the Faculty of Health Sciences. After his pre-med studies, he went on to complete a Masters degree in Medical Laboratory Sciences at the Nelson Mandela Metropolitan University where he was offered a post as lecturer in the department. His doctorate investigated the histopathology found in male wistar rats after chronic consumption of an extract of the plant Sutherlandia frutescencs which is used in South Africa by the indigeneous people to lower blood sugar in patients with type two diabetes. has a background in chemistry (BSc, University of Edinburgh and MSc, University College London) and holds a PhD in stem cell bioprocessing from the Advanced Centre for Biochemical Engineering, University College London. Emily is Director of the London Regenerative Medicine Network (LRMN), which has over 5,500 members. Emily represents the LRMN on the British Regen Industry Tool Set project funded by the Technology Strategy Board and is a regular author of industry-orientated publications. She also works as an Associate for Proteus Venture Partners and is an advisor to the internationally-acknowledged stem cell and regenerative medicine lawyers, Lawford Davies Denoon (London, UK).       Nicolas Wickens completed his Doctorate from the Nelson Mandela University in South Africa. He is a lecturer of pathology in the Department of Medical Technology and Radiography in the Faculty of Health Sciences. After his pre-med studies, he went on to complete a Masters degree in Medical Laboratory Sciences at the Nelson Mandela Metropolitan University where he was offered a post as lecturer in the department. His doctorate investigated the histopathology found in male wistar rats after chronic consumption of an extract of the plant Sutherlandia frutescencs which is used in South Africa by the indigeneous people to lower blood sugar in patients with type two diabetes. has a background in chemistry (BSc, University of Edinburgh and MSc, University College London) and holds a PhD in stem cell bioprocessing from the Advanced Centre for Biochemical Engineering, University College London. Emily is Director of the London Regenerative Medicine Network (LRMN), which has over 5,500 members. Emily represents the LRMN on the British Regen Industry Tool Set project funded by the Technology Strategy Board and is a regular author of industry-orientated publications. She also works as an Associate for Proteus Venture Partners and is an advisor to the internationally-acknowledged stem cell and regenerative medicine lawyers, Lawford Davies Denoon (London, UK).    

Genetics and Molecular Biology